A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT00042328
- Phase
- PHASE2
- Status
- Completed
Conditions
- Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir — DRUG
Study Details
The purpose of this research is to study the pharmacology (how the body handles this drug) of valacyclovir in children receiving treatment for cancer. This study will last approximately 7 days.
Key Dates
- Start date
- Aug 31, 2001
- Status verified
- Aug 2015
- Primary completion
- May 31, 2005
- Completion
- May 31, 2005
Study Design
- Enrollment
- 30 participants
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Texas Children's Hospital | Houston | Texas | - | - |
Find similar trials in Houston, TX
By research site
Related Studies
- Registry Study for Radiation Therapy OutcomesRecruiting · Proton Collaborative Group · Scottsdale, Arizona
- Adoptive Cell Therapy Long-term Follow-up (LTFU) StudyPHASE1 · Recruiting · USWM CT, LLC · Atlanta, Georgia
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPHASE2/PHASE3 · Recruiting · Celgene · Birmingham, Alabama
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsPHASE1 · Recruiting · M.D. Anderson Cancer Center · Birmingham, Alabama